PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
226.57%
Net income growth above 1.5x EQT's 21.27%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-48.89%
Both reduce yoy D&A, with EQT at -10.35%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
1240.68%
Well above EQT's 580.22% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
98.30%
Slight usage while EQT is negative at -26.54%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Some yoy usage while EQT is negative at -1952.90%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-23.02%
Negative yoy while EQT is 363.76%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
21.05%
Operating cash flow growth below 50% of EQT's 215.97%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
18.58%
Some CapEx rise while EQT is negative at -23.76%. John Neff would see competitor possibly building capacity while we hold back expansions.
-155.78%
Negative yoy acquisition while EQT stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
168.74%
Purchases growth of 168.74% while EQT is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-162.53%
We reduce yoy sales while EQT is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-157.56%
Both yoy lines negative, with EQT at -99.03%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
365.10%
We have mild expansions while EQT is negative at -493.21%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
17.77%
Debt repayment growth of 17.77% while EQT is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
227.31%
Issuance growth of 227.31% while EQT is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-186831.83%
Both yoy lines negative, with EQT at -9.44%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.